FILE:COV/COV-8K-20071018091748.txt.gz
EVENTS:	Other Events	Financial Statements and Exhibits
TEXT:
ITEM: Other Events
ITEM: Financial Statements and Exhibits
 
 
 
 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 
 
 
 
On October 18, 2007, Covidien Ltd. issued a press release announcing that its wholly-owned subsidiary, Covidien International Finance S.A. ("CIFSA") priced an offering of $2.75 billion aggregate principal amount of fixed rate senior notes to qualified institutional buyers pursuant to rule 144A of the Securities Act of 1933 (the "Securities Act") and to non-U.S. persons in reliance on Regulation S under the Securities Act.
A copy of the press release is attached hereto as Exhibit 99.1, is incorporated herein by reference and is hereby filed.
 
 
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Date: October 18, 2007

Exhibit 99.1
Date: October 18, 2007
Covidien Announces Pricing of $2.75 Billion Fixed Rate Senior Notes Offering
PEMBROKE, Bermuda  Covidien Ltd. (NYSE: COV; BSX: COV) today announced that its wholly-owned subsidiary, Covidien International Finance S.A. (CIFSA), has priced an offering of $2.75 billion aggregate principal amount of fixed rate senior notes to qualified institutional buyers pursuant to Rule 144A of the Securities Act of 1933 (the "Securities Act") and to non-U.S. persons in reliance on Regulation S under the Securities Act.
The $250,000,000 Notes due 2010 will be issued at a price of 99.892%, plus accrued interest, and will bear interest at a rate of 5.15% per year, payable semi-annually; the $500,000,000 Notes due 2012 will be issued at a price of 99.864%, plus accrued interest, and will bear interest at a rate of 5.45% per year, payable semi-annually; the $1,150,000,000 Notes due 2017 will be issued at a price of 99.927%, plus accrued interest, and will bear interest at a rate of 6.00% per year, payable semi-annually; and the $850,000,000 Notes due 2037 will be issued at a price of 99.560%, plus accrued interest, and will bear interest at a rate of 6.55% per year, payable semi-annually.
The notes will be CIFSA's senior unsecured obligations and will rank equally in right of payment with all of its existing and future senior debt, and senior to any subordinated indebtedness that CIFSA may incur. These notes are fully and unconditionally guaranteed on a senior unsecured basis by Covidien Ltd.
The transaction is expected to settle on October 22, 2007.
Covidien intends to use the net proceeds of this offering to repay a portion of its borrowings under its unsecured bridge loan facilities, of which $3.201 billion is currently drawn.
The notes will not be registered under the Securities Act or the securities laws of any other jurisdiction and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act.
This announcement does not constitute an offer to sell or the solicitation of offers to buy any security and shall not constitute an offer, solicitation, or sale of any security in any jurisdiction in which such offer, solicitation, or sale would be unlawful.
 


